ABSTRACT

Triple antigen hepatitis B vaccine, recombinant (international nonproprietary name)

Description: Hepacare is a recombinant hepatitis B vaccine consisting of purified pre-S1, pre-S2, and S surface hepatitis B antigens. It is produced by recombinant DNA technology in murine cells and is supplied in a prefilled syringe as a suspension (20 µg/ml) for intramuscular injection.